IdentifAI Genetics, established by ShizimVS Innovation Center and is one of its portfolio companies, has completed a $ 0.7 million pre-seed investment. The company continues the current round until the completion of $ 1 million investment.
IdentifAI Genetics is a non-invasive prenatal single-gene-disorder using a simple blood test taken from a pregnant woman at week 10, the technology enables complete genetic sequencing of the baby's DNA.
The test can identify most of the existing genetic mutations, but early in pregnancy, risk-free and without the need for an invasive procedure.
The company's leading team includes, Professor Noam Shomron, PhD., Chief Scientific Officer, Head of the Functional Genomics Laboratory and Director of the Djerassi Institute of Oncology at Tel Aviv University and a Co-founder of several Biotech companies, Oren Tadmor, CEO, 25 years of experience as Israeli Air Force large-scale technological projects manager and F-16 Squadron commander; and Tom Rabinowitz, MD. PhD Chief Research Officer, expert in detection of diseases using advanced algorithms and artificial intelligence, awarded several prizes and scholarships.
IdentifAI Genetics already presented a Proof Of Concept, and currently validates real cases.
Just like Amniocentesis.
The company plans to revolutionize the way parental tests are performed worldwide.
